Inhibikase Therapeutics, Inc. (IKT) vs Quantum-Si incorporated (QSI)
A side-by-side comparison of Inhibikase Therapeutics, Inc. and Quantum-Si incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IKT
Inhibikase Therapeutics, Inc.
$2.01HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
QSI
Quantum-Si incorporated
$1.25HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — IKT vs QSI
growth of $100 · dividends reinvested · last 6yIKT -96.6% (-43.2%/yr)QSI -87.2% (-29.0%/yr)QSI compounded faster over this window
IKT QSI
IKT vs QSI: by the numbers
- •IKT is the larger company ($265M vs $246M market cap).
- •Both run net losses; IKT's is the smaller (0.00% vs -6138.26% net margin).
Metrics side by side
Valuation
| Metric | IKT | QSI |
|---|---|---|
| P/S ratio | N/A | 153.45 |
| P/B ratio | 1.73 | 1.37 |
Profitability
| Metric | IKT | QSI |
|---|---|---|
| Gross margin | 0.00% | 47.33% |
| Operating margin | 0.00% | -3996.72% |
| Net margin | 0.00% | -6138.26% |
| ROE | -39.55% | -54.67% |
| ROIC | -42.92% | -51.87% |
Growth (annualized)
| Metric | IKT | QSI |
|---|---|---|
| Total return CAGR (5Y) | -29.10% | -31.06% |
Frequently asked
- How have IKT and QSI total returns compared?
- Over the past 5 years, IKT delivered -29.10% and QSI delivered -31.06% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.